Telmisartan (40mg) + Rosuvastatin (10mg)
Tellzy-RS Tablet is used in the treatment of high blood pressure with high cholesterol.
1 Strip of 15 Tablet
Alembic Pharmaceuticals Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tellzy-RS Tablet may be taken with or without food, but it is better to take it at a fixed time.
Tellzy-RS Tablet is a combination of two medicines: Telmisartan and Rosuvastatin which treat high blood pressure and cholesterol. Telmisartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels and lowering blood pressure. Rosuvastatin is a lipid-lowering medication (statin). It works by blocking an enzyme (HMG-CoA-reductase) that is required in the body to make cholesterol. It thus lowers "bad" cholesterol (LDL), triglycerides and raises "good" cholesterol (HDL).
Related Warnings
Taking alcohol with Rosuvastatin increases the chances of liver dysfunction.
Tellzy-RS Tablet is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
Tellzy-RS Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Tellzy-RS Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Tellzy-RS Tablet should be used with caution in patients with kidney disease. Dose adjustment of Tellzy-RS Tablet may be needed. Please consult your doctor.
Use of Tellzy-RS Tablet is not recommended in patients with severe kidney disease.
Tellzy-RS Tablet should be used with caution in patients with liver disease. Dose adjustment of Tellzy-RS Tablet may be needed. Please consult your doctor.
Use of Tellzy-RS Tablet is not recommended in patients with severe liver disease and active liver disease.
